New aspects on biological activity of C-peptide in IDDM patients

Experimental and Clinical Endocrinology and Diabetes

Volumn 106, Issue 4, 1998, Pages 270-276

  Forst, T ^a,c   Kunt, T ^a   Pfutzner A ^a   Beyer, J ^a   Wahren, J ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

C peptide; Diabetic complications; IDDM

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); C PEPTIDE; GLUCOSE; INSULIN; NITRIC OXIDE SYNTHASE;

AUTONOMIC NERVE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVATION; GLOMERULUS FILTRATION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; KIDNEY FUNCTION; MUSCLE BLOOD FLOW; NERVE FUNCTION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REVIEW; SKIN BLOOD FLOW;

EID: 0031669705     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212190     Document Type: Review

References (70)

1. Birnbaumer L, Abramowitz J, Brown AM: Receptor-effector coupling by G proteins. Biochim Biophys Acta 1031: 163-224, 1990
2. Cameron NE, Cotter MA, Low PA: Nerve blood flow in early experimental diabetic rats: relation to conduction deficits. Am J Physiol 261: E1-E8, 1991
3. Cohen P, Barzilai N, Karnieli E: Suppression of insulin secretion by C-peptide infusion m humans. Isr J Med Sci 31: 284-288, 1995
4. Dyck PJ, Brown M, Green D: Does impropved control of glycaemia prevent or ameliorate diabetic polyneuropathy? Ann Neurol 19: 288-290, 1986
5. Etgen GJ Jr, Fryburg DA, Gibbs EM: Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction-and phosphatidylinositol-3-kinase-independent pathway. Diabetes 46: 1915-1919, 1997
6. Ferrannini E, Björkmann O, Reichard JR, Pilo A, Olsson M, Wahren J, De Fronzo RA: The disposal of an oral glucose load in healthy subjects. Diabetes 34: 580-588, 1985
7. Forst T, Kunt T, Pohlmann T, Goitom K, Engelbach M, Beyer J, Pfützner A: Biological activity of C-peptide on the skin microcirculation in patients with IDDM. J Clin Invest 101: 2036-2041, 1998
8. Greene DA, Lattimer SA, Sima AAF: Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Eng J Med 316: 599-606, 1987
9. +ATPase, conduction and myo-inositolin the insulin dependent BB rat. Am J Physiol 247: 534-539, 1984
10. Harati Y: Diabetic peripheral neuropathies. Ann Intern Med 107: 546-559, 1987
11. Hoogwerf BJ, Bantle JP, Gaenslen HE, Greenberg BZ, Senske BJ, Francis R, Goetz FC: Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects. Metabolism 35: 122-125, 1986
12. Horwitz DL, Kuzuya H, Rubenstein AH: Circulating serum C-peptide: a brief review of diagnostic implications. N Engl J Med 295: 207-209, 1976
13. Horwitz DL, Starr JI, Mako E, Blackard WE, Rubenstein AH: Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood. J Cin Invest 55: 1278-1283, 1975
14. Huang W, Sjöquist M, Johansson BL, Wahren J: Acute effects of human C-peptide on renal function in the early stage of experimental diabetes. Diabetologia 37 (Suppl 1): A7, 1994
15. Ido Y, Vindigni A, Chang K, Stramm L, Chance R, Heath WF, DiMarchi RD, DiCera E, Williamson JR: Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 277: 563-566, 1997
16. Johansson B-L, Borg K, Fernqvist-Forbes E, Odergren T, Remahl S, Wahren J: C-peptide improves autonomic nerve function in IDDM patients Diabetologia 39: 687-695, 1996
17. Johansson B-L, Fernqvist-Forbes E, Wahren J: Effects of C-peptide on nephropathy and neuropathy in IDDM-patients-a clinical study. Diabetologia 37 (Suppl 1): A7, 1995
18. Johansson B-L, Kernell A, Sjöberg S, Wahren J: Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 77: 976-981, 1993
19. Johansson B-L, Linde B, Wahren J: Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilisation in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 1151-1158, 1992
20. Johansson B-L, Sjöberg S, Wahren J: The influence of human C-peptide on renal function and glucose utilisation in type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 121-128, 1992
21. Jörneskog G, Tyden G, Bolinder J, Fagrell B: Does combined kidney and pancreas transplantation reverse functional diabetic microangiopathy? Transplant Int 3: 167-170, 1990
22. Jörneskog G, Tyden G, Bolinder J, Fagrell B: Skin microvascular reactivity in fingers of diabetic patients after combined kidney and pancreas transplantation. Diabetologia 34 (Suppl 1): 135-137, 1991
23. Kemler W, Peterson JD, Rubenstein AH, Steiner DF: On the biosynthesis, intracellular transport and mechanism of conversation of proinsulin to insulin and C-peptide. Diabetes 21 (Suppl. 2): 572-581, 1972
24. Kernell A, Ludvigsson J, Finnström K: Vitreous fluorophotometry in insulin-dependent diabetes mellitus. Acta Ophthlmologica 68: 415-420, 1990
25. Kitabchi AE: The bilogical and immunological properties of pork and beef insulin, proinsulin, and connecting peptides. J Clin Invest 49: 979-987, 1970
26. Kunt T, Wallerath T, Forst T, Closs E, Lehmann R, Flohr T, Gabriel M, Schäfer D, Göpfert A, Pfützner A, Beyer J, Förstermann U: C-peptide stimulates endothelial nitric oxide sythase by increasing the influx of calcium into endothelial cells. J Clin Invest, submitted
27. Leclercq-Meyer V, Malaisse EJ, Johansson BL, Wahren J: Effect of C-peptide on insulin and glucagon release by isolated perfused rat pancreas. Diabetes Metab 23: 149-154, 1997
28. Lindström K, Johansson C, Johnsson E, Haraldsson B: Acute effects of C-peptide on the microvasculature of isolated perfused skeletal muscles and kidneys in rat. Acta Physiol Scand 156: 19-25, 1996
29. Lückhoff A, Busse R: Activators of potassium chanels enhance calcium influx into endothelial cells as a consequence of potassium currents. Naunyn Schmiedbergs Arch Pharmacol 342: 94-99
30. Madsbad S: Factors of importance for residual β-cell function in type 1 diabetics. A Review. Acta Med Scand 671: 61-67, 1983
31. Malik RA, Tesfaye S, Thompson SD, Veves A, Sharma AK, Boulton AJM, Ward JD: Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia 36: 454-459, 1993
32. Mogensen CE, Andersen MJF: Increased kidney size and glomerular filtration rate in untreated juvenile diabetes. Diabetes 22: 706-712, 1973
33. Mogensen CE, Andersen MJF: Increased kidney size and glomerular filtration rate in untreated juvenile diabetes. Normalisation by insulin treatment. Diabetologia 20: 199-204, 1975
34. Moncada S, Palmer RMJ: The L-arginine nitric oxide pathway in the vessel wall. In: Moncada S, Higgs, eds. Nitric Oxide from L-arginine: a bioregulatory system. Amsterdam, Netherlands: Elsevier 19-33, 1990
35. Newrick PG, Wilson AJ, Jakubowski J, Boulton AJM, Ward JD: Sural nerve oxygen tension in diabetes. Br Med J 293: 1053-1054, 1986
36. +ATPase activity and its alpha II subunit gene expression in rat skeletal muscle: influence of diabetes, fasting and refeeding. Metabolism 41: 56-63, 1992
37. +ATPase activity in synergism with neuropeptide Y. Diabetologia 39: 199-205, 1996
38. +ATPase activity of renal tubule segments. Diabetologia 41: 287-291, 1998
39. Over PE, Cho S, Peterson JD: Studies on human proinsulin: isolation and amino acid sequence of the human pancreatic C-peptide. J Biol Chem 246: 1375-1386, 1971
40. Pirart J: Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1: 168-252, 1978
41. +ATPase acitivity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy. Diabete et Metab 18: 236-241, 1992
42. Rubenstein AH, Clark JL, Melani F, Steiner DF: Secretion of proinsulin C-peptide by pancreatic beta cells and its circulation in blood. Nature 224: 697-699, 1969
43. Sandahl-Christiansen J, Frandsen M, Parving HH: The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia 20: 199-204, 1981
44. +-ATPase in the pathogenesis of human diabetic neuropathy. J Neurol Sci 120: 159-167, 1993
45. Shigeta H, Yamaguchi M, Nakano K, Obayashi H, Takemura R, Fukui M, Fujii M, Yoshimori K, Hasegawa G, Nakamura N, Kitagawa Y, Kondo M: Serum antibodies against sulfatide and phospholipid in NIDDM patients with diabetic neuropathy. Diabetes Care 20: 1896-1899, 1997
46. Sjöberg S, Gunnarsson R, Gjötterberg M, Persson M, Östman J: Residual insulin production and prevalence of microvascular lesions and polyneuropathy in long term type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 208-213, 1987
47. Sjöberg S, Johansson B-L, Östman J, Wahren J: Renal and splanchnic exchange of human biosynthetic C-peptide in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34: 423-428, 1991
48. Solomon SS, Brush JS, Kitabchi AE: Antilipolytic activity of insulin and proinsulin on ACTH and cyclic nucleotide-induced lipolysis in the isolated adipose cell of rat. Biochim Biophys Acta 218: 167-169, 1970
49. Steiner DF: On the role of the proinsulin C-peptide. Diabetes 27 (Suppl 1): 145-148, 1978
50. Steiner DF, Over PE: The biosynthesis of insulin and probable precursor of insulin by a human islet cell adenoma. Proc Natl Acad Sci 57: 473-480, 1967
51. Stoll RW, Touber JL, Menahan LA, Williams RH: Clearance of porcine insulin, proinsulin and connecting peptide by the isolated rat liver. Proc Soc Exp Biol Med 111: 894-896, 1970
52. Tesfaye S, Harris N, Jakubowski JJ, Mody C, Wilson RM, Rennie IG, Ward JD: Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 36: 1266-1274, 1993
53. Tesfaye S, Malik R, Harris N, Jakubowski JJ, Mody C, Rennie IG, Ward JD. Arterio-venous shunting and proliferating new vessels in acute pamfull neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 39: 329-335, 1996
54. Tomlinson DR, Smith WJ, Walker J, Keen P: Neuronal gene expression and axonal flux in experimental diabetic neuropathy. Diabete Metab 16: 350-351, 1990
55. Tuck RR, Schmelzer JD, Low PA: Endoneurial blood flow and oxygen tension the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107: 935-950,1984
56. Van Ravenswaaij-Arts CMA, Kollee LAA, Hopman JCW, Stoelinga GBA, van Gerijn HP: Heart rate variability. Ann Intern Med 118: 436-447, 1993
57. Vinik AI, Leichter SB, Pittenger GL, Stansberry KB, Holland MT, Powers AC, Suwanwalaikorn S: Phospholipid and glutamic acid decarboxylase autoantibodies in diabetic neuropathy. Diabetes Care 18: 1225-1232, 1995
58. Vlassara H, Brownlee M, Cerami A: Recognition and uptake of human diabetic peripheral nerve myelin by macrophages. Diabetes 34: 553-557, 1985
59. Wahren J, Johansson B-L: New aspects of C-peptide physiology. Horm Metab Res 30: A2-A5, 1998
60. Wahren J, Johansson B-L, Wallberg-Henriksson H, Linde B, Fernqvist-Forbes E, Zierath JR: C-peptide revisted - new physiological effects and therapeutic implications. J Intern Med 240: 115-124, 1996
61. +ATPase in diabetes mellitus: relationship to metabolic abnormality. Am J Physiol 265: F96-F101, 1993
62. Willars GB, Calcutt NA, Tomlinson DR: Reduced anterograd and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase ihibitor "statil". Dibetologia 30: 239-243, 1987
63. Wojcikowski C, Blackman J, Ostrega D, Lewis G, Galloway J, Rubenstein AH, Polonsky KS: Lack of effect on high dose biosynthetic human C-peptide on pancreatic hormone release in normal subjects. Metabolism 39: 827-832, 1990
64. Wojcikowski C, Maier V, Fussgänger R, Pfeiffer EF: Effects of synthetic rat C-peptide in normal and diabetic rats. Diabetologia 25: 288-290, 1983
65. Yu SS, Kitabchi AE: Biological activity of proinsulin and related polypeptides in the fat tissue. J Biol Chem 248: 3753-3761, 1973
66. Zanone MM, Peakman M, Purewal T, Watkins PJ, Vergani D: Autoantibodies to nervous tissue structures are associated with autonomic neuropathy in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36: 564-569,1993
67. Ziegler D: Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis, and treatment. Diabetes Metab Rev 10: 339-383, 1995
68. Ziegler D, Mayer P, Gries FA: Evaluation of thermal, pain, and vibration sensation threshold in newly diagnosed type 1 diabetic patients. J Neurol Neurosurg Psychiat 51: 1420-1424, 1988
69. Zierath JR, Galuska D, Johansson BL, Wallberg-Henriksson H: Effect of human C-peptide in glucose transport in in vitro incubated human skeletal muscle. Diabetologia 34: 899-901, 1991
70. Zierath JR, Handberg A, Tally M, Wallberg-Henriksson H: C-peptide stimulates glucose transport in isolated human skelatal muscle independent of insulin receptor and tyrosin kinase activation. Diabetologia 39: 306-313, 1996